[P4–575]: ALZ‐801 MECHANISM OF ACTION: STOICHIOMETRY OF BETA AMYLOID ANTI‐OLIGOMER EFFECT, PK/PD, AND CLINICAL DOSE SELECTION FOR CONFIRMATORY PHASE 3 PROGRAM IN ALZHEIMER's DISEASE. (1st July 2017) - Hey, John; Kocis, Petr; Abushakra, Susan; Yu, Jeremy; Power, Aidan; Blennow, Kaj; Tolar, Martin